Trials / Withdrawn
WithdrawnNCT00382746
EarlySense Monitoring Device Evaluation on CHF Patients
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- EarlySense Ltd. · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
CHF patients will be monitored using EarlySense ES-16 device and will simultaneously fill diaries and log their weight daily. The data collected and analyzed by the ES-16 device will be correlated with the CHF status data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EarlySense monitoring device |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-11-01
- Completion
- 2008-03-01
- First posted
- 2006-09-29
- Last updated
- 2016-07-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00382746. Inclusion in this directory is not an endorsement.